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Psychological Factors Relevant to the Prehospital and In-hospital
Phases of Acute Myocardial Infarction

Lori W. Kenyon, PhD,* Mark W. Ketterer, PhD,* and Richard C. Preisman, MD*

Recognition and treatment of psychological factors relevant to the acute prehospital and in-hospital
phases of myocardial infarction (Ml) are reviewed. Various emotions and personality characteristics
can be both risk factors for and consequences of acute Ml. Components trf the Type A behavior pattern
and levels of somatic and emotional awareness have been linked with excessive treatment-seeking
delay for Ml patients. Psychiatric condhions such as panic disorder may mimic symptomatic
presentation trf Ml and therefore have implications for differential diagnosis in the emergency room.
Additionally. anxiety, depression, and neurobehavioral disorders such as delirium are relatively
common during the hosphalization period and may contribute to potentially lethal CompUcations of
Ml. Because psychological factors are associated with prognosis during each phase of Ml. the
identiftcation and treatment of such factors are crucial in providing comprehensive care for MI
patients. (Heniy Ford Hosp Med J 1991:39:176-83)

A

n interplay between the mind and the heart has been recognized since 1628, with William Harvey's statement (1),
"Every affection of the mind that is attended with either pain or
pleasure, hope or fear, is the cause of an agitation whose influence extends to the heart." Subsequent evidence has accumulated indicating that various emotions appear to serve both as
risk factors for and consequences of heart disease. This is perhaps most apparent in the case of acute myocardial infarction
(MI). As described by Johnston (2), prior research has suggested
that M I is more likely to occur in persons who are aggressive
and over-busy or depressed (3), phobic (4), or have poor social
support (5,6). Furthermore, emotional distress has been demonstrated to be a frequent consequence of M I , as a heart attack is a
profound event which presents potential psychiatric as well as
physiologic morbidity.

Prehospital Phase: Psychological Factors
AfTecting Treatment-Seeking Behavior
Survival in the acute phase of M I and the subsequent prognosis are critically dependent upon the early application of medical
interventions, particularly thrombolytic and other reperfusion
therapies. The effectiveness of these therapies is limited by the
elapse of time from symptom onset to the patient's arrival at the
hospital. Most ofthis total delay time appears to be the length of
time it takes for patients to decide they are ill and to seek medical attention (7-11). Prior studies have had difficulty identifying
significant factors that explain pafients' delay in responding to
M I symptoms. The majority of investigations have concluded
that neither demographic nor medical history variables such as
age, socioeconomic status, sex, or prior M I reliably predict delay time. Though few studies have examined psychological factors related to this delay, the following variables have been im-
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plicated as affecting delay time: Type A behavior pattem, denial, and somatic and emotional awareness.
Type A behavior
Hackett and Cassem (12) suggested that the tendency to deny
negative features of experience may delay Type A individuals
from seeking medical help for early symptoms of coronary heart
disease (CHD). Greene and others (13) inferred from clinical
observations that Type A persons prefer to avoid reporting early
heart attack symptoms rather than face the prospect of being a
patient and not being able to work. In 1983, Matthews and associates (9) examined Type A behavior, assessed by the Structured
Interview, and its relation to illness decisions by M I patients.
They found that those patients who delayed in the early phase of
treatment-seeking (time between symptom onset and illness decision) characteristically displayed elevated anger levels, a component factor of Type A behavior. Once patients had recognized
they were ill. Type B behavior was associated with a longer delay in seeking medical attention. It was unclear whether the general Type A behavior pattem was significantly correlated with
the total delay interval—fime from symptom onset to decision
to seek medical treatment. Two other recent studies (11,14)
found no significant relationship between Type A behavior and
treatment-seeking delay for M I patients. In 1991, Nolan and
Wielgosz (15) expanded the notion of the Type A behavior pattem to include concepts of adaptive versus maladaptive coping
styles, judged by the Structured Interview. They investigated
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MI patients' self-management of cardiac symptoms, including
delay in deciding to seek treatment, as related to general coping
behaviors. Results indicated that patients characterized as maladaptive copers, defined by elevated scores on Type A behavior
and its components, demonstrated greater use of distraction and
individual-based relief-seeking behaviors for MI symptoms,
which appeared to put them at risk of increased delays prior to
deciding to seek treatment for MI symptoms. The authors concluded that there is a need to caution MI patients against overutilizing distraction and relief-seeking behaviors, as they may
inierfere with the patient's ability to identify and quickly respond to symptoms of acute cardiovascular disease.
Denial
Although il is generally believed lhal all patients in the acute
stages of MI deny to some extent that they are experiencing a
heart attack (16), the role of denial in effecting decisions to seek
treatment has not been assessed thoroughly. Two prior studies
have failed to observe significant relationships between denial
and decision time (11.17). As Wielgosz and colleagues (11) discussed, an important limitation to the study of denial has been
the lack of an appropriate psychometric instrument. It may be
that a major component of denial in cardiovascular disease is a
reduced awareness of bodily and/or emotional sensations.
Somatic and emotional nonawareness
Kenyon and associates (14) recentiy discovered evidence that
reduced awareness of bodily sensations and emotions (emotional
nonawareness = "alexithymia") powerfully predicted treatmentseeking delay for MI patients. Factors affecting time between
symptom onset and hospital arrival for 103 MI patients admitted
to Henry Ford Hospital were examined. Though neither demographic nor medical history variables were significantiy associated with delay time, patients better able to identtfy emotions
and/or bodily sensations sought treatment significantly earlier
than patients with low emotional and/or somatic awareness (low
emotional awareness median delay = 12.8 hours; high emotional awareness median delay = 3.8 hours; low somatic awareness median delay = 7 hours; high somatic awareness median
delay = 4 hours). Whether or not patients believed they were
having a heart attack as well as the perceived salience of symptoms also were powerful correlates of treatment-seeking delay and appeared to mediate the relationship between somatic
awareness and delay time. However, emotional nonawareness
remained significantly associated with delay time even with
these two variables controlled. Patients with low somatic awareness appeared less likely to believe they were having a heart attack and reported less salient symptoms and therefore were less
likely to seek medical attention promptiy. However, even with
these two intra-event factors considered, emotional nonawareness remained a powerful predictor of delay time.
A related investigation (18) examining silent versus symptomatic ischemia found that patients with evidence of silent
ischemia on thallium stress testing were less aware of cardiac
and other bodily sensations and were less avoidant of harm and
pain in general than patients with symptomatic ischemia.
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From a pragmatic clinical standpoint, perhaps the most important aspect of these findings is that information on levels of
somatic and emotional awareness is premorbidly available. Assessment of these characteristics in patients with coronary risk
factors could allow early identification and appropriate interventions for persons at risk of excessive delay in responding to
symptoms of MI.

Differential Diagnosis in the Emergency Room
Cardiac disease may mimic psychiatric disorder and vice
versa. As noted by Vitaliano and associates (19), differentiating
chest pain caused by CHD and other organic etiologies from that
associated with a psychiatric disorder is often difficult. For example, panic attacks and cardiac arrhythmias or MI share many of
the same symptoms, such as dyspnea, palpitafions, light-headedness, and autonomic arousal (20). Further complicating differential diagnosis, emotional stressors can serve to trigger both
panic attacks and arrhythmias or sudden cardiac death (21; reviewed by Frank and Smith [22]), and certain cardiac medications—beta-blockers, for example—may diminish panic symptoms as well as symptoms stemming from cardiac disease.
In addition to diagnostic testing to mle out organic disease, a
correct diagnosis can be facilitated by a detailed history of
symptoms (20). For example, while syncope is common in severe arrhythmias, it is uncommon in panic attacks. Arrhythmias
also tend to vary in duration from seconds to days, whereas the
course of panic attacks is more typical, usually lasting between
5 to 20 minutes (20). While a family history of anxiety disorder
increases the likelihood of panic attacks in the patient, it does
not preclude the presence of CHD.
Cardiac disease and somatoform disorders (e.g., psychogenic
pain disorder, somatization disorder) are at times mistaken for
each other but also frequentiy coexist (20). Emotions are frequently somaticized into chest pain, both in patients with and
without significant heart disease (23). Mayou (24) described
that atypical or noncardiac chest pain is frequently seen in patients in medical outpatient clinics, emergency rooms (25,26),
and cardiac care units (CCUs) (27,28). Persons presenting with
chest pain without identifiable organic pathology are often anxious and/or depressed (29-31). Such patients appear to contribute to the 10% to 30% of patients found to have no or nominal
occlusions on cardiac catheterization (19). In fact, 33% to 46%
of patients with normal coronary arteries on angiogram display
panic disorder (23,29,32). Although follow-up studies of patients with chest pain but normal angiograms have consistently
indicated a good physical outcome (33,34), many patients report
persistent chest pain, emotional distress, impairment of social
and occupational activities, and ongoing use of cardiac and
other medical resources (35). Although the cause of disability in
patients with normal coronary arteries is not entirely clear, a recent study indicated that patients with normal angiograms who
also have panic disorder are more disabled than those without
panic disorder (36).
Because of the emotional distress and disability in patients
with atypical chest pain, as well as the financial aspects of continuing use of medical services, it is important that effective
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treatment strategies for these patients be identified and utilized.
There is encouraging evidence that interventions directed toward associated psychological problems can result in improvement of mood, relief of chest pain, and decreased limitations of
daily living (24,37-40).
Mention should also be made of the interrelation between
substance use disorders, specifically cocaine use, and MI. As
discussed by Tokarski and colleagues (41), the most prominent
adverse reaction secondary to cocaine use is MI occurring in
otherwise healthy, young individuals. Approximately 58 cases
of acute MI temporally related to cocaine ingestion have been
reported to date in the English-language literature (42). These
persons were characteristically young, male, chronic users of
cocaine, and without any antecedent cardiac history.
As cocaine use has escalated, the frequency of emergency
room visits by cocaine abusers complaining of chest pain after
cocaine use has also increased (41). Such patients who have
ECG evidence of myocardial injury are easily identified. However, a more difficult diagnostic and treatment planning dilemma is presented by patients who complain of chest pain but
have a normal or nondiagnostic ECG. In 1990, Tokarski and
others (41) found evidence, based on creafine kinase (CK) and
CK isoenzymes, of acute myocardial cellular injury in cocaine
abusers complaining of chest pain, even though ECGs were normal or nondiagnosfic. As the researchers recommended, more
research is needed to determine the significance of such findings
for long-term prognosis, as a cocaine-induced cardiomyopathy
may be a potenfial long-term consequence (41).

Emotional and Neuropsychiatric Sequelae
in the Hospitalization Period
MI is a profound psychological event. Patients' beliefs regarding impending death and real or imagined losses can and
should change most of their lives forever. For some patients,
these changes actually enrich or improve life. However, for
many others these changes diminish the quality of life, leading
potentially to physical incapacity, sexual difficulfies, financial
insecurity, and confiicts in familial role.
The most obvious and immediate reacfion to MI is anxiety.
Fear of disability and death is a common source of anxiety. Additional causes include nervousness associated with CCU procedures or events such as codes, ward rounds (43), or transfer to
a general hospital floor. Explanations regarding the nature of
these events and reassurance can help to minimize these concems. In addition to emotional sources of anxiety, it is important
to mle out potenfial organic causes of anxiety in MI patients
(Table). Furthermore, because 20% of the general population
have preexisting mental disorders (44), MI patients may come to
the CCU with a premorbid anxiety disorder.
Anxiety in MI patients can be manifested in a variety of ways.
Some patients are overtly vigilant and distressed and may experience a sense of dread or foreboding. Objective indicators of
anxiety in-hospital may include tachycardia, tachypnea, diaphoresis, insomnia, hypertension, and ventricular ectopy (43).
Other patients may overtly appear to be quietly watchful, surprisingly calm, or unconcerned about the implications of their
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Table
Organic Conditions Generating Anxiety Symptoms
in Myocardial Infarction Patients
• Medication side effects
Antiarrhythmics
Digitalis
Anticholinergics
Bronchodilators
Stimulants
• Withdrawal from sedatives, hypnotics, opiates
• Electrolyte abnormalities
Diuretic therapy
Kidney dysfunction
• Endocrine disorders
Thyroid disease
• Hypoglycemia, hyperglycemia
• Hypocalcemia, hypercalcemia
• Pulmonary embolism
• Central nervous system dysfunction
Acute embolic stroke
Hypoxia
Early delirium
Atypical seizures
• Pain

condition. The latter are referred to as engaging in "denial." Denial can refer to lack of appropriate concem over one's medical
status or a lack of belief in the gravity of the diagnosis. Extreme
cases have been observed in which patients at discharge deny
having had a MI despite ECG and enzyme confirmation of the
diagnosis. This belief may be driven by anxiety over the implications of the diagnosis or caused by personality characteristics
such as suspiciousness or mistmsL
Patients who engage in denial present a dilemma. The fear
imposed upon a patient by a MI initiates what should be the start
of reorientation of priorities and restmcturing of life-style. Yet
the absence of anxiety probably has short-term benefits. Studies
of denial in medical populations indicate that such patients have
shorter hospital stays and fewer complications while in the hospital. Yet the same patients have poorer long-term prognoses,
presumably because of inadequate compliance or concem over
controlling risk factors (45).
Monitoring of emotional state is rarely done systematically in
the CCU. Overt distress is typically noted by nursing staff and
will often lead to discussion and/or pharmacological treatment.
Some patients may remain quietiy distressed out of fear of acknowledging their anxiety because doing so may lead to a temporary increase in subjective intensity and/or staff intrusions.
Others may be unaware of their distress because of severely restricted attentional focus (46) or difficulties in identifying and
describing their emofions accurately (47). Thus, monitoring of
the patient's emotional state should encompass both the patient's subjective report and his or her nonverbal behavior. Restlessness, distractibility, tenseness, hypervigilance, frequent or
easily initiated startle responses, tics, insomnia, irritability, noncompliance, and frequent complaining over minor matters all
can be indications of anxiety. Fluctuating cardiac parameters
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that cannot be accounted for by other factors may also be indicators of anxiety.
Estimates of the prevalence of depression in various cardiac
populations average about 30% or four to five times that seen in
the general population (48,49). Reactive causes include grief
and loss of self-esteem related to fears of disability and loss of
potency secondary to the Ml. Recent work has indicated that
some of the observed dysphoria occurs premorbidly and may be
a risk factor for acute ischemic events (50-58). Additionally, depressed mood may represent a major depressive disorder (55) or
a dysthymic disorder caused by a combination of life circumstances and personality characteristics such as being an excessive worrier, hyperconscientious, and/or unreasonably responsible (52,57).
Impact on cardiac morbidity and mortality
Emotional reactions in the emergency room and CCU are important in and of themselves. Moreover the emotional distress
associated with Ml may be partially responsible for potentially
lethal complications of MI, such as cardiogenic shock and arrhythmia (43). Recent prospective studies have raised the question of "psychopathogenesis": Does the acutely anxious patient
have a worse prognosis? The studies on denial might be taken
to imply that they do. Prior to the advent of beta-blockers and
thrombolytics, the benefit of CCU admission for MI patients
was questioned by some (59) and may atfimeshave been deleterious (60,61). Such studies raised questions about "psychological toxicity" of the CCU. The highly technical environment, intensive staff observation, episodic codes, and disruption of normal sleep pattems probably foster anxiety in some patients. Do
such emotional states contribute to the biology of ischemic heart
disease? The psychopathogenesis of ischemic CHD is under active investigation (22,62,63).
Indirect behaviorally-mediated mechanisms, such as increased
smoking or caffeine use, may explain part of the relationship between emotional stress and Ml (64,65). However, to date, these
mechanisms have not been able to account fully for the results of
epidemiologic studies. The residual relationship of stress to the
pathogenesis of MI may be accounted for by emotional influences on neural and neuroendocrine activity. For example, catecholamine release during acute and/or chronic emotional distress (66,67) may increase platelet aggregation (68-72). Acute
changes in such thrombotic factors as platelet Factor IV, [3thromboglobulin, von Willebrand factor, fibrinopeptide-A, and
thromboxane (3, have been observed in response to experimental or natural stressors (73-77). Type A individuals, who are
characterized by chronic performance anxiety and irritability,
have also been observed to have increased platelet aggregability
(78,79). Acute psychological stressors have also been observed
to increase ischemia demonstrated by ECG (80-83) and wall
motion abnormalities demonstrated by echocardiography (84)
or thallium imaging (85). Stress-prone personality characteristics also seem to be correlates of increased ischemia (86) and
general coronary artery disease (87). Such effects may be catecholamine or serotonin mediated (88-90). Furthermore, ventricular arrhythmias appear to be influenced by heightened emotional arousal (91,92), and personality characteristics or psycho-
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social stressors appear related to arrhythmias. A variety of personality, emotional, and social factors have been associated
with ventricular premature beats, ectopic beats, lengthening or
shortening of the QT interval, and/or ventricular tachycardia
(93-96). Unfortunately, such studies to date have not controlled
for associated behavioral mechanisms, such as concomitant elevated caffeine use (65,97).
Management of acute emotional arousal during MI
Many of the signs and symptoms of emotional distress are
mediated by the cardiovascular system and accompanied by increased activity of the sympathetic nervous system (43). Especially because of the already vulnerable myocardium of the MI
patient, emotional distress, if left untreated, may enhance the
risk of potentially lethal complications of MI. Thus, the recognition and treatment of psychiatric complications of MI is critical.
As alluded to previously, once anxiety has been identified, organic sources of the symptoms should first be ruled out. The
possibility of preexisting anxiety disorders should also be explored, and continuation of preadmission psychotropics should
be maintained unless there are medical contraindications. Some
manifestations of anxiety in the CCU may be attenuated by pblockade, narcotic use, and informal interactions between patients and .staff. Reassurance by staff is accomplished in several
ways. Some patients are reassured merely by being under observation and are able to entmst themselves to the system while
others require frequent or repetitious explanations of the events
taking place around them. Conversely, some patients wish to
know few details of their care. In such cases, it is best to leave
them to their own coping style as long as their care is going well.
Because beliefs regarding the Ml are major determinants of cardiac invalidism (98), it is important that MI patients receive detailed explanations of what to expect regarding physical recovery. Specific areas of importance include work schedules, sexual activity, and cardiac rehabilitation (43).
At one time it was common to provide MI patients with central nervous system (CNS) depressants such as phenobarbital or
Valium. With more recent advances in acute care, such practices
appear to have become less common, and benzodiazepines have
replaced barbiturates as drugs of choice for treatment of anxiety
(43). However, randomly assigned, placebo-controlled clinical
trials of benzodiazepine use by MI patients are lacking. Nonetheless, prudent judicious use of such medications seems warranted. Benzodiazepines are known to be effecttve at alleviating
transitory anxiety and may decrease platelet aggregation (99,
100). Given the circumstances operative in the emergency room
and CCU, routine use of a scheduled, as opposed to as necessary, benzodiazepine should be considered. Absolute contraindications include sleep apnea (101,102) and respiratory insufficiency. Relative contraindications might include a history of
substance abuse, although the benefits might well outweigh the
risks for such individuals.
After a diagnosis of depression has been confirmed, organic
causes should be ruled out. As discussed by Stern (43), the
work-up should include screening of electrolytes, calcium, and
magnesium and thyroid function tests. Medications frequentiy
used in cardiac patients which may have depressant properties
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include some antihypertensives and beta-blockers, especially
propranolol. Assuming that organic causes have been ruled out,
depression is best treated during the first days to weeks afler
a Ml by reassurance, emotional support, and early ambulation/
rehabilitation. Tricyclic anfidepressants, because of their impact on conduction and other anticholinergic effects, are best
avoided until the myocardium is well healed and the PR and QT
intervals have retumed to normal. Where depression is severe,
unresponsive to psychological treatment, and/or presents a danger in which treatment cannot be delayed by several weeks, nontraditional pharmacological agents such as alprazolam and even
psychostimulants (dextroamphetamine and methylphenidate)
have been used with relative safety in acute cardiac settings (43).
Pharmacological treatment of the cardiovascular components
of anxiety may be insufficient to control all of the associated risks (103,104). Psychological techniques provide another
means of controlling anxiety and have the added advantages of
providing the patient with methods of increasing self-control
and potentially long-term risk modification. Techniques used in
alleviating acute anxiety include distraction, relaxafion, education, support, and cognifive therapy. Distracfion might involve
nothing more than a radio or television to capture the patient's
attention and thus reduce ruminative preoccupation with every
passing chest sensafion or the meaning of every word spoken by
staffi Relaxafion training may be difficult in the hectic CCU environment but provides patients with skills to calm themselves
and restore some sense of personal control over events. The
transient effects of emotion on sympathetic arousal are well documented (66,67), and relaxation is also well documented at reversing such effects (105). Cognitive therapy aimed at identifying and modifying the patient's erroneous beliefs can be greatly
helpful to some patients. Psychological interventions with MI
patients have been reported to alleviate emotional distress, reduce the length of hospitalization and subsequent use of medical
services, and decrease the occurrence of congestive heart failure
and arrhythmia (106-108).

Neurobehavioral Difficulties in MI Patients
Because of the association of advancing age both with cardiac
disease and with cognitive impairment (109), disturbed behavior and its neurological implications can be important issues
in the management of MI. These disturbances of brain function
are among the most frequent syndromes seen in the hospital
(110) and in clinical care in general (111). Approximately 3% of
Americans age 55 or older have severe cognitive impairment,
and an additional 10% have mild cognitive impairment (109).
This latter figure suggests that a significant number of patients
suffering a MI potentially have difficulty understanding, remembering, and complying with medical explanafions and recommendations. They may have additional behavioral difficulties undergoing treatment and rehabilitation. Therefore, recognition and appropriate management of such disorders is clinically important.
Neurobehavioral disorders can be diagnosed with relative
ease at the bedside, especially those where global impairment of
cognition is present. Globally impaired cognition is classified
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either as dementia or delirium. Four signs are essential for the
diagnosis of global impairment, although other behavioral features are frequently present. Disorders of orientation, recent
memory, and intellectual capacity and inability to sustain attention and wakefulness are cardinal diagnostic features of global
cognitive impairment. A patient who is able to sustain attention
and wakefulness but has the other three features noted above is
usually demented. If wakefulness and attention are impaired in
addition, delirium is usual. Other behavioral features, such as
mood disturbance, hallucinations, paranoia, agitation, or lethargy, are frequently present but are unnecessary or insufficient
for diagnosis. These problems are most important for management, however, and may appear to be the most obvious behavioral features on initial examination.
Differentiation of dementia from delirium is important for
several reasons. Although dementia will often present with management problems, urgency of work-up is usually not an issue.
Delirium, however, implies a need for urgent evaluation because a substantial mortality risk is correlated with this syndrome (109). The etiology of delirium is either toxic, metabolic,
infective, seizure-related, or due to structural problems in the
CNS. Delirium has been reported to occur in 2% to 12% of CCU
patients (112,113). Stem (43) discussed common causes of delirium in the cardiac patient population to include: CNS compromise secondary to cardiac arrest, anemia, hypoxia, low cardiac output, and dmg toxicity. Many cardiac medications are associated with delirium (20,114,115). For example, antiarrhythmic medications, digitalis preparations, aminophylline preparations, some antihypertensives, and occasionally beta-blockers
can be problematic. Posttransplantafion recipients (116) and
postcardiotomy patients (117) also are at risk for delirium.
Psychopharmacology plays a role in the management of both
demenfia and delirium, but the underlying etiology must be
sought if prolonged improvement in delirium is to be gained.
While the search for the cause of the delirium is in progress, antipsychotic medication (e.g., haloperidol, 0.5 to 5.0 mg daily)
often will ameliorate psychotic symptoms associated with these
syndromes. Protective restraint is also frequently necessary to
prevent patients from unintentionally harming themselves or
others (e.g., falls, removing catheters or arterial lines). If delirium is caused by withdrawal of CNS depressants (e.g., alcohol,
barbiturates), the most appropriate treatment involves reintoxicating the patient with a cross-tolerant drug (e.g., a benzodiazepine) and then gradually withdrawing the medication. "Dmg
protocols" (e.g., phenobarbital, lorazepam) are currently being
used for withdrawal of CNS depressants, but many patients
require custom-dosing of drugs to undergo safisfactory withdrawal, as effecfive doses of medication vary substantially from
person to person. Occasionally, antipsychotic medication is a
helpful adjunct in withdrawing CNS depressant dmgs.

Conclusions
The disability associated with Ml has psychiatric as well as
physiologic manifestations. Furthermore, psychological factors
are strongly associated with prognosis during each phase of MI,
from the prehospital through the convalescent periods, and in
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many cases enhance morbidity and mortality for infarction patients. Therefore, the identificafion and treatment of such factors
are cmcial in providing comprehensive care for MI patients.
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